To include your compound in the COVID-19 Resource Center, submit it here.

Metadate CD: Phase IV; marketed

In a 3-week double-blind, placebo-controlled Phase IV U.S. trial in 184 pediatric patients ages

Read the full 146 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE